A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

Summary

This study will evaluate the safety, tolerability, and pharmacokinetics of BLYG8824A and will make a preliminary assessment of the anti-tumor activity of BLYG8824A in patients with locally advanced or metastatic colorectal cancer.

Timeline

Start

2020-08-31

Primary completion

2024-10-16

Completion

2024-10-16

Drugs

Indications